Advisory Committee Meeting
AdComFDA & Regulatory
An FDA Advisory Committee (AdCom) meeting convenes independent external experts to review a drug’s data and vote on whether its benefits outweigh its risks. The vote is non-binding, but the FDA usually follows it, so AdCom outcomes are major pre-PDUFA catalysts.
Related terms
Learn more
Track Advisory Committee Meeting across 1,000+ biotechs
BioSniper monitors FDA decisions, clinical trials, and catalysts in real time — with evidence-backed AI analysis.
Start Free